nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2B—Pitavastatin—Rosuvastatin—atherosclerosis	0.0307	0.634	CbGdCrCtD
Dexrazoxane—Neoplasm malignant—Ezetimibe—atherosclerosis	0.0143	0.015	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.0125	0.0131	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.0122	0.0128	CcSEcCtD
Dexrazoxane—Sensory loss—Pravastatin—atherosclerosis	0.0122	0.0128	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.0116	0.0122	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.0105	0.0111	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.0104	0.0109	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.0102	0.0107	CcSEcCtD
Dexrazoxane—Oesophagitis—Niacin—atherosclerosis	0.00977	0.0103	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00972	0.0102	CcSEcCtD
Dexrazoxane—Breast disorder—Rosuvastatin—atherosclerosis	0.00964	0.0101	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00879	0.00923	CcSEcCtD
Dexrazoxane—Depression—Rosuvastatin—atherosclerosis	0.00819	0.00861	CcSEcCtD
Dexrazoxane—Breast disorder—Ezetimibe—atherosclerosis	0.00801	0.00842	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00798	0.00839	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00782	0.00822	CcSEcCtD
Dexrazoxane—Infestation NOS—Ezetimibe—atherosclerosis	0.00683	0.00718	CcSEcCtD
Dexrazoxane—Infestation—Ezetimibe—atherosclerosis	0.00683	0.00718	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00674	0.00708	CcSEcCtD
Dexrazoxane—Dysphagia—Niacin—atherosclerosis	0.00671	0.00705	CcSEcCtD
Dexrazoxane—Depression—Simvastatin—atherosclerosis	0.0065	0.00683	CcSEcCtD
Dexrazoxane—Mental disorder—Rosuvastatin—atherosclerosis	0.00646	0.00679	CcSEcCtD
Dexrazoxane—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.00609	0.126	CbGdCrCtD
Dexrazoxane—Oedema peripheral—Ezetimibe—atherosclerosis	0.00604	0.00635	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00603	0.00633	CcSEcCtD
Dexrazoxane—Weight decreased—Pravastatin—atherosclerosis	0.00598	0.00628	CcSEcCtD
Dexrazoxane—Depression—Pravastatin—atherosclerosis	0.00587	0.00617	CcSEcCtD
Dexrazoxane—Stomatitis—Niacin—atherosclerosis	0.00583	0.00613	CcSEcCtD
Dexrazoxane—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.00582	0.12	CbGdCrCtD
Dexrazoxane—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.00582	0.12	CbGdCrCtD
Dexrazoxane—Cough—Rosuvastatin—atherosclerosis	0.0056	0.00589	CcSEcCtD
Dexrazoxane—Angiopathy—Ezetimibe—atherosclerosis	0.00556	0.00585	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00553	0.00581	CcSEcCtD
Dexrazoxane—Alopecia—Lovastatin—atherosclerosis	0.00553	0.00581	CcSEcCtD
Dexrazoxane—Myalgia—Rosuvastatin—atherosclerosis	0.00547	0.00575	CcSEcCtD
Dexrazoxane—Alopecia—Ezetimibe—atherosclerosis	0.00542	0.0057	CcSEcCtD
Dexrazoxane—Haemoglobin—Niacin—atherosclerosis	0.0054	0.00567	CcSEcCtD
Dexrazoxane—Mental disorder—Ezetimibe—atherosclerosis	0.00537	0.00565	CcSEcCtD
Dexrazoxane—Haemorrhage—Niacin—atherosclerosis	0.00537	0.00564	CcSEcCtD
Dexrazoxane—Erythema—Ezetimibe—atherosclerosis	0.00534	0.00561	CcSEcCtD
Dexrazoxane—Malnutrition—Ezetimibe—atherosclerosis	0.00534	0.00561	CcSEcCtD
Dexrazoxane—Oedema peripheral—Niacin—atherosclerosis	0.00529	0.00556	CcSEcCtD
Dexrazoxane—Infection—Rosuvastatin—atherosclerosis	0.00521	0.00547	CcSEcCtD
Dexrazoxane—Alopecia—Simvastatin—atherosclerosis	0.00517	0.00543	CcSEcCtD
Dexrazoxane—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00514	0.0054	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00513	0.00539	CcSEcCtD
Dexrazoxane—Mental disorder—Simvastatin—atherosclerosis	0.00512	0.00538	CcSEcCtD
Dexrazoxane—Tremor—Lovastatin—atherosclerosis	0.0051	0.00536	CcSEcCtD
Dexrazoxane—Erythema—Simvastatin—atherosclerosis	0.00509	0.00535	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Lovastatin—atherosclerosis	0.00505	0.00531	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00495	0.00521	CcSEcCtD
Dexrazoxane—Anaemia—Ezetimibe—atherosclerosis	0.00493	0.00519	CcSEcCtD
Dexrazoxane—Malaise—Lovastatin—atherosclerosis	0.00491	0.00516	CcSEcCtD
Dexrazoxane—Cardiac disorder—Pravastatin—atherosclerosis	0.00491	0.00516	CcSEcCtD
Dexrazoxane—Angiopathy—Niacin—atherosclerosis	0.00487	0.00512	CcSEcCtD
Dexrazoxane—Leukopenia—Lovastatin—atherosclerosis	0.00487	0.00512	CcSEcCtD
Dexrazoxane—Malaise—Ezetimibe—atherosclerosis	0.00481	0.00506	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00478	0.00502	CcSEcCtD
Dexrazoxane—Tremor—Simvastatin—atherosclerosis	0.00477	0.00501	CcSEcCtD
Dexrazoxane—Alopecia—Niacin—atherosclerosis	0.00475	0.00499	CcSEcCtD
Dexrazoxane—Insomnia—Rosuvastatin—atherosclerosis	0.00474	0.00498	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Simvastatin—atherosclerosis	0.00472	0.00496	CcSEcCtD
Dexrazoxane—Anaemia—Simvastatin—atherosclerosis	0.00471	0.00495	CcSEcCtD
Dexrazoxane—Erythema—Niacin—atherosclerosis	0.00467	0.00491	CcSEcCtD
Dexrazoxane—Malnutrition—Niacin—atherosclerosis	0.00467	0.00491	CcSEcCtD
Dexrazoxane—Alopecia—Pravastatin—atherosclerosis	0.00467	0.00491	CcSEcCtD
Dexrazoxane—Cough—Ezetimibe—atherosclerosis	0.00466	0.0049	CcSEcCtD
Dexrazoxane—Myalgia—Lovastatin—atherosclerosis	0.00463	0.00487	CcSEcCtD
Dexrazoxane—Malaise—Simvastatin—atherosclerosis	0.00459	0.00483	CcSEcCtD
Dexrazoxane—Discomfort—Lovastatin—atherosclerosis	0.00458	0.00481	CcSEcCtD
Dexrazoxane—Leukopenia—Simvastatin—atherosclerosis	0.00456	0.00479	CcSEcCtD
Dexrazoxane—Myalgia—Ezetimibe—atherosclerosis	0.00454	0.00478	CcSEcCtD
Dexrazoxane—Dry mouth—Lovastatin—atherosclerosis	0.00453	0.00476	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00451	0.00474	CcSEcCtD
Dexrazoxane—Discomfort—Ezetimibe—atherosclerosis	0.00449	0.00472	CcSEcCtD
Dexrazoxane—Pain—Rosuvastatin—atherosclerosis	0.00448	0.00471	CcSEcCtD
Dexrazoxane—Constipation—Rosuvastatin—atherosclerosis	0.00448	0.00471	CcSEcCtD
Dexrazoxane—Dry mouth—Ezetimibe—atherosclerosis	0.00444	0.00467	CcSEcCtD
Dexrazoxane—Infection—Lovastatin—atherosclerosis	0.00441	0.00464	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Lovastatin—atherosclerosis	0.00435	0.00457	CcSEcCtD
Dexrazoxane—Myalgia—Simvastatin—atherosclerosis	0.00433	0.00456	CcSEcCtD
Dexrazoxane—Infection—Ezetimibe—atherosclerosis	0.00433	0.00455	CcSEcCtD
Dexrazoxane—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00432	0.00454	CcSEcCtD
Dexrazoxane—Tremor—Pravastatin—atherosclerosis	0.00431	0.00453	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00429	0.0045	CcSEcCtD
Dexrazoxane—Discomfort—Simvastatin—atherosclerosis	0.00428	0.0045	CcSEcCtD
Dexrazoxane—Nervous system disorder—Ezetimibe—atherosclerosis	0.00427	0.00449	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Pravastatin—atherosclerosis	0.00427	0.00449	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00427	0.00448	CcSEcCtD
Dexrazoxane—Anaemia—Pravastatin—atherosclerosis	0.00425	0.00447	CcSEcCtD
Dexrazoxane—Anorexia—Lovastatin—atherosclerosis	0.00423	0.00445	CcSEcCtD
Dexrazoxane—Skin disorder—Ezetimibe—atherosclerosis	0.00423	0.00445	CcSEcCtD
Dexrazoxane—Syncope—Niacin—atherosclerosis	0.00419	0.00441	CcSEcCtD
Dexrazoxane—Leukopenia—Niacin—atherosclerosis	0.00418	0.0044	CcSEcCtD
Dexrazoxane—Urticaria—Rosuvastatin—atherosclerosis	0.00416	0.00438	CcSEcCtD
Dexrazoxane—Malaise—Pravastatin—atherosclerosis	0.00415	0.00436	CcSEcCtD
Dexrazoxane—Abdominal pain—Rosuvastatin—atherosclerosis	0.00414	0.00435	CcSEcCtD
Dexrazoxane—Infection—Simvastatin—atherosclerosis	0.00413	0.00434	CcSEcCtD
Dexrazoxane—Leukopenia—Pravastatin—atherosclerosis	0.00412	0.00433	CcSEcCtD
Dexrazoxane—Loss of consciousness—Niacin—atherosclerosis	0.00411	0.00432	CcSEcCtD
Dexrazoxane—Cough—Niacin—atherosclerosis	0.00408	0.00429	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Simvastatin—atherosclerosis	0.00407	0.00428	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00405	0.00425	CcSEcCtD
Dexrazoxane—Insomnia—Lovastatin—atherosclerosis	0.00402	0.00422	CcSEcCtD
Dexrazoxane—Cough—Pravastatin—atherosclerosis	0.00402	0.00422	CcSEcCtD
Dexrazoxane—Myalgia—Niacin—atherosclerosis	0.00398	0.00418	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00397	0.00417	CcSEcCtD
Dexrazoxane—Anorexia—Simvastatin—atherosclerosis	0.00396	0.00416	CcSEcCtD
Dexrazoxane—Dyspnoea—Lovastatin—atherosclerosis	0.00396	0.00416	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00395	0.00415	CcSEcCtD
Dexrazoxane—Insomnia—Ezetimibe—atherosclerosis	0.00394	0.00414	CcSEcCtD
Dexrazoxane—Myalgia—Pravastatin—atherosclerosis	0.00392	0.00412	CcSEcCtD
Dexrazoxane—Dry mouth—Niacin—atherosclerosis	0.00389	0.00409	CcSEcCtD
Dexrazoxane—Dyspnoea—Ezetimibe—atherosclerosis	0.00388	0.00408	CcSEcCtD
Dexrazoxane—Discomfort—Pravastatin—atherosclerosis	0.00387	0.00407	CcSEcCtD
Dexrazoxane—Decreased appetite—Lovastatin—atherosclerosis	0.00386	0.00406	CcSEcCtD
Dexrazoxane—Fatigue—Lovastatin—atherosclerosis	0.00383	0.00402	CcSEcCtD
Dexrazoxane—Constipation—Lovastatin—atherosclerosis	0.0038	0.00399	CcSEcCtD
Dexrazoxane—Pain—Lovastatin—atherosclerosis	0.0038	0.00399	CcSEcCtD
Dexrazoxane—Decreased appetite—Ezetimibe—atherosclerosis	0.00379	0.00398	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00379	0.00398	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00376	0.00395	CcSEcCtD
Dexrazoxane—Asthenia—Rosuvastatin—atherosclerosis	0.00376	0.00395	CcSEcCtD
Dexrazoxane—Insomnia—Simvastatin—atherosclerosis	0.00376	0.00395	CcSEcCtD
Dexrazoxane—Fatigue—Ezetimibe—atherosclerosis	0.00376	0.00395	CcSEcCtD
Dexrazoxane—Shock—Niacin—atherosclerosis	0.00375	0.00394	CcSEcCtD
Dexrazoxane—Infection—Pravastatin—atherosclerosis	0.00373	0.00392	CcSEcCtD
Dexrazoxane—Pain—Ezetimibe—atherosclerosis	0.00373	0.00392	CcSEcCtD
Dexrazoxane—Constipation—Ezetimibe—atherosclerosis	0.00373	0.00392	CcSEcCtD
Dexrazoxane—Pruritus—Rosuvastatin—atherosclerosis	0.00371	0.0039	CcSEcCtD
Dexrazoxane—Skin disorder—Niacin—atherosclerosis	0.00371	0.00389	CcSEcCtD
Dexrazoxane—Dyspnoea—Simvastatin—atherosclerosis	0.0037	0.00389	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Pravastatin—atherosclerosis	0.00368	0.00387	CcSEcCtD
Dexrazoxane—Feeling abnormal—Lovastatin—atherosclerosis	0.00366	0.00385	CcSEcCtD
Dexrazoxane—Anorexia—Niacin—atherosclerosis	0.00364	0.00382	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00363	0.00382	CcSEcCtD
Dexrazoxane—Decreased appetite—Simvastatin—atherosclerosis	0.00361	0.0038	CcSEcCtD
Dexrazoxane—Feeling abnormal—Ezetimibe—atherosclerosis	0.00359	0.00377	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00359	0.00377	CcSEcCtD
Dexrazoxane—Diarrhoea—Rosuvastatin—atherosclerosis	0.00359	0.00377	CcSEcCtD
Dexrazoxane—Fatigue—Simvastatin—atherosclerosis	0.00358	0.00376	CcSEcCtD
Dexrazoxane—Anorexia—Pravastatin—atherosclerosis	0.00358	0.00376	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00356	0.00374	CcSEcCtD
Dexrazoxane—Pain—Simvastatin—atherosclerosis	0.00355	0.00373	CcSEcCtD
Dexrazoxane—Constipation—Simvastatin—atherosclerosis	0.00355	0.00373	CcSEcCtD
Dexrazoxane—Urticaria—Lovastatin—atherosclerosis	0.00353	0.00371	CcSEcCtD
Dexrazoxane—Abdominal pain—Lovastatin—atherosclerosis	0.00351	0.00369	CcSEcCtD
Dexrazoxane—Body temperature increased—Lovastatin—atherosclerosis	0.00351	0.00369	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00348	0.00365	CcSEcCtD
Dexrazoxane—Dizziness—Rosuvastatin—atherosclerosis	0.00347	0.00364	CcSEcCtD
Dexrazoxane—Urticaria—Ezetimibe—atherosclerosis	0.00346	0.00364	CcSEcCtD
Dexrazoxane—Insomnia—Niacin—atherosclerosis	0.00345	0.00363	CcSEcCtD
Dexrazoxane—Abdominal pain—Ezetimibe—atherosclerosis	0.00344	0.00362	CcSEcCtD
Dexrazoxane—Body temperature increased—Ezetimibe—atherosclerosis	0.00344	0.00362	CcSEcCtD
Dexrazoxane—Feeling abnormal—Simvastatin—atherosclerosis	0.00342	0.0036	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00342	0.0036	CcSEcCtD
Dexrazoxane—Dyspnoea—Niacin—atherosclerosis	0.0034	0.00357	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0034	0.00357	CcSEcCtD
Dexrazoxane—Insomnia—Pravastatin—atherosclerosis	0.0034	0.00357	CcSEcCtD
Dexrazoxane—Somnolence—Niacin—atherosclerosis	0.00339	0.00356	CcSEcCtD
Dexrazoxane—Dyspnoea—Pravastatin—atherosclerosis	0.00335	0.00352	CcSEcCtD
Dexrazoxane—Decreased appetite—Niacin—atherosclerosis	0.00332	0.00349	CcSEcCtD
Dexrazoxane—Urticaria—Simvastatin—atherosclerosis	0.0033	0.00347	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Niacin—atherosclerosis	0.00329	0.00346	CcSEcCtD
Dexrazoxane—Abdominal pain—Simvastatin—atherosclerosis	0.00328	0.00345	CcSEcCtD
Dexrazoxane—Body temperature increased—Simvastatin—atherosclerosis	0.00328	0.00345	CcSEcCtD
Dexrazoxane—Headache—Rosuvastatin—atherosclerosis	0.00328	0.00345	CcSEcCtD
Dexrazoxane—Decreased appetite—Pravastatin—atherosclerosis	0.00327	0.00343	CcSEcCtD
Dexrazoxane—Pain—Niacin—atherosclerosis	0.00326	0.00343	CcSEcCtD
Dexrazoxane—Fatigue—Pravastatin—atherosclerosis	0.00324	0.0034	CcSEcCtD
Dexrazoxane—Constipation—Pravastatin—atherosclerosis	0.00321	0.00338	CcSEcCtD
Dexrazoxane—Pain—Pravastatin—atherosclerosis	0.00321	0.00338	CcSEcCtD
Dexrazoxane—Asthenia—Lovastatin—atherosclerosis	0.00319	0.00335	CcSEcCtD
Dexrazoxane—Pruritus—Lovastatin—atherosclerosis	0.00314	0.0033	CcSEcCtD
Dexrazoxane—Asthenia—Ezetimibe—atherosclerosis	0.00313	0.00329	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Niacin—atherosclerosis	0.00312	0.00328	CcSEcCtD
Dexrazoxane—Nausea—Rosuvastatin—atherosclerosis	0.00311	0.00327	CcSEcCtD
Dexrazoxane—Feeling abnormal—Pravastatin—atherosclerosis	0.0031	0.00325	CcSEcCtD
Dexrazoxane—Pruritus—Ezetimibe—atherosclerosis	0.00308	0.00324	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00307	0.00323	CcSEcCtD
Dexrazoxane—Diarrhoea—Lovastatin—atherosclerosis	0.00304	0.00319	CcSEcCtD
Dexrazoxane—Urticaria—Niacin—atherosclerosis	0.00303	0.00319	CcSEcCtD
Dexrazoxane—Abdominal pain—Niacin—atherosclerosis	0.00302	0.00317	CcSEcCtD
Dexrazoxane—Body temperature increased—Niacin—atherosclerosis	0.00302	0.00317	CcSEcCtD
Dexrazoxane—Urticaria—Pravastatin—atherosclerosis	0.00298	0.00314	CcSEcCtD
Dexrazoxane—Asthenia—Simvastatin—atherosclerosis	0.00298	0.00313	CcSEcCtD
Dexrazoxane—Diarrhoea—Ezetimibe—atherosclerosis	0.00298	0.00313	CcSEcCtD
Dexrazoxane—Body temperature increased—Pravastatin—atherosclerosis	0.00297	0.00312	CcSEcCtD
Dexrazoxane—Abdominal pain—Pravastatin—atherosclerosis	0.00297	0.00312	CcSEcCtD
Dexrazoxane—Pruritus—Simvastatin—atherosclerosis	0.00294	0.00309	CcSEcCtD
Dexrazoxane—Dizziness—Lovastatin—atherosclerosis	0.00294	0.00309	CcSEcCtD
Dexrazoxane—Dizziness—Ezetimibe—atherosclerosis	0.00288	0.00303	CcSEcCtD
Dexrazoxane—Diarrhoea—Simvastatin—atherosclerosis	0.00284	0.00299	CcSEcCtD
Dexrazoxane—Vomiting—Lovastatin—atherosclerosis	0.00282	0.00297	CcSEcCtD
Dexrazoxane—Headache—Lovastatin—atherosclerosis	0.00278	0.00292	CcSEcCtD
Dexrazoxane—Vomiting—Ezetimibe—atherosclerosis	0.00277	0.00291	CcSEcCtD
Dexrazoxane—Dizziness—Simvastatin—atherosclerosis	0.00275	0.00289	CcSEcCtD
Dexrazoxane—Asthenia—Niacin—atherosclerosis	0.00274	0.00288	CcSEcCtD
Dexrazoxane—Headache—Ezetimibe—atherosclerosis	0.00273	0.00287	CcSEcCtD
Dexrazoxane—Pruritus—Niacin—atherosclerosis	0.0027	0.00284	CcSEcCtD
Dexrazoxane—Asthenia—Pravastatin—atherosclerosis	0.0027	0.00283	CcSEcCtD
Dexrazoxane—Pruritus—Pravastatin—atherosclerosis	0.00266	0.00279	CcSEcCtD
Dexrazoxane—Vomiting—Simvastatin—atherosclerosis	0.00264	0.00278	CcSEcCtD
Dexrazoxane—Nausea—Lovastatin—atherosclerosis	0.00264	0.00277	CcSEcCtD
Dexrazoxane—Diarrhoea—Niacin—atherosclerosis	0.00261	0.00274	CcSEcCtD
Dexrazoxane—Headache—Simvastatin—atherosclerosis	0.0026	0.00274	CcSEcCtD
Dexrazoxane—Nausea—Ezetimibe—atherosclerosis	0.00259	0.00272	CcSEcCtD
Dexrazoxane—Diarrhoea—Pravastatin—atherosclerosis	0.00257	0.0027	CcSEcCtD
Dexrazoxane—Dizziness—Niacin—atherosclerosis	0.00252	0.00265	CcSEcCtD
Dexrazoxane—Dizziness—Pravastatin—atherosclerosis	0.00248	0.00261	CcSEcCtD
Dexrazoxane—Nausea—Simvastatin—atherosclerosis	0.00247	0.00259	CcSEcCtD
Dexrazoxane—Vomiting—Niacin—atherosclerosis	0.00243	0.00255	CcSEcCtD
Dexrazoxane—Headache—Niacin—atherosclerosis	0.00239	0.00251	CcSEcCtD
Dexrazoxane—Vomiting—Pravastatin—atherosclerosis	0.00239	0.00251	CcSEcCtD
Dexrazoxane—Headache—Pravastatin—atherosclerosis	0.00235	0.00247	CcSEcCtD
Dexrazoxane—Nausea—Niacin—atherosclerosis	0.00227	0.00238	CcSEcCtD
Dexrazoxane—Nausea—Pravastatin—atherosclerosis	0.00223	0.00234	CcSEcCtD
